Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis
- 28 December 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (26), 1732-1736
- https://doi.org/10.1056/nejm199512283332603
Abstract
Pregnant women with bacterial vaginosis may be at increased risk for preterm delivery. We investigated whether treatment with metronidazole and erythromycin during the second trimester would lower the incidence of delivery before 37 weeks' gestation.Keywords
This publication has 28 references indexed in Scilit:
- Plasma cell endometritis in women with symptomatic bacterial vaginosisObstetrics & Gynecology, 1995
- Safety of metronidazole in pregnancy: A meta-analysisAmerican Journal of Obstetrics and Gynecology, 1995
- Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysisJAMA, 1992
- Prenatal microbiological risk factors associated with preterm birthBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in PrematurityNew England Journal of Medicine, 1988
- Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcomePublished by American Medical Association (AMA) ,1986
- Anaerobic Bacteria in Nonspecific VaginitisNew England Journal of Medicine, 1980
- Nonspecific VaginitisNew England Journal of Medicine, 1978
- Rapid diagnosis of anaerobic infections by gas-liquid chromatography of clinical material.Journal of Clinical Pathology, 1976
- Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments.JCI Insight, 1976